News Briefing channel feed – Endpoints News

News Briefing channel feed

Repair, Genevant ink deal worth up to $107M; 858 Therapeutics raises $50M

8 months ago

Corrected: Sanofi inks deal with I-Mab spinout; Wave discloses $175M offering on heels of DMD data

8 months ago

Capricor to begin filing DMD drug with FDA next month; Surrozen’s $10M milestone

8 months ago

Context makes a T cell engager deal; Ginkgo Bioworks backers have a new SPAC

8 months ago

Ascendis aims to raise $300M; Basilea inks up to $268M deal with BARDA

8 months ago

Capricor expands DMD pact with Nippon Shinyaku; AbbVie’s new eye deal

8 months ago

Nuvalent's $350M offering; FDA lifts partial hold on Zentalis drug

8 months ago

Valneva raises about €61M; Immuneering details new Phase 2a data

8 months ago

GSK’s mRNA flu shot is heading to Phase 3; Summit’s $235M offering

8 months ago

Xencor’s $175M offering; Viridian to raise $150M

8 months ago

Ionis’ $500M offering; Terns aims to raise $125M

8 months ago

Immunovant shares mid-stage Graves’ disease data; FDA lifts Rezolute’s hold

8 months ago

Basilea records $25M milestone; Connect Biopharma reduces workforce in China

8 months ago

Novartis pays $15M upfront to license Voyager program; Boehringer advances geographic atrophy drug

8 months ago

Vaxcyte aims to raise $1B after sharing pneumococcal vaccine data; More layoffs at Genentech

8 months ago

Denali details accelerated approval plans; Jazz's $850M private offering

8 months ago

Jacobio's China rights deal; Reneuron off the London exchange

8 months ago

J&J heads to FDA for Vyvgart competitor; Tokyo conglomerate launches venture fund

8 months ago

SpringWorks gets priority review; Botox competitor data; Hyundai's Covid treatment; Arcus takes a loan

9 months ago

Redalpine closes $200M fund; A base editing pact in China; Merck starts another Phase 3 for Imago drug

9 months ago

Mpox vaccine collab; $11M oncology seed; Gates backs RSV vaccine; Kyowa Kirin slims portfolio

9 months ago

Novo's innovation hub expands to Bay Area; SIGA's new Tpoxx order

9 months ago

Vandria raises another $10M; Nykode ends Phase 2 trial in cervical cancer

9 months ago

Kymera seeks to raise $225M; Adcendo, Multitude's new ADC deal

9 months ago

First page Previous page 4 5 678 9 10 Next page Last page